Intuitive Surgical, US46120E6023

Intuitive Surgical stock last trades at USD 414.55 on September 28, 2026

Published on 09/28/2026 at 20:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock last traded at USD 414.55 on September 28, 2026, up 2.31 percent. The company’s latest release highlighted a meta-analysis of da Vinci surgery outcomes.

Fotorealistischer Operationssaal mit einem generischen Roboterchirurgiesystem mit vier Instrumentenarmen über einem blau drapierten Patienten, helles OP-Licht, unscharfe Chirurgensilhouetten im Hintergrund
Intuitive Surgical US46120E6023 zeigt fotorealistischen generischen OP-Roboter mit vier Armen im sterilen Operationssaal, Illustration mit AI erstellt.

Intuitive Surgical stock last traded at USD 414.55 on the Nasdaq on September 28, 2026, at 18:53:04 UTC. The stock was up 2.31 percent, or USD 9.37, from the previous close of USD 405.18.

Trading session

The quote reflects regular-session trading in Intuitive Surgical, Inc.’s primary listed instrument. The price and daily change are presented separately from the company’s latest disclosed development.

Meta-analysis examines da Vinci outcomes

On September 8, 2026, Intuitive Surgical, Inc. announced the publication of a systematic review and meta-analysis in Annals of Surgery Open. According to the company’s GlobeNewswire release, the analysis covered more than 14 million da Vinci, laparoscopic and open procedures across 13 common benign conditions.

The release said da Vinci surgery was associated with 54 percent lower odds of conversion to open surgery and hospital stays approximately four hours shorter than laparoscopic surgery. The analysis synthesized 14 years of published evidence from 32 countries and reported no statistically significant differences in complications, infections, readmissions or 30-day mortality between da Vinci and laparoscopic surgery.

Disclaimer...

en | US46120E6023 | INTUITIVE SURGICAL | boerse | 70194746 | bgmi